Antabio
PrivateLast Round
Series B
Dec 12, 2023
Total Funding Raised
$61.74M
Momentum Score
25 /100
Company Overview
Antabio is a biopharmaceutical company specializing in innovative antibacterial treatments for drug-resistant infections, particularly targeting critical pathogens associated with severe respiratory conditions.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antabio Comps
Public and private peers based on sector, stage, and business model.
Antabio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 12, 2023 | ||||
| Grant | Mar 16, 2021 | ||||
| Grant | Jan 2, 2020 | ||||
| Series A | Jul 12, 2018 | ||||
| Grant | Jul 25, 2017 | ||||
Grant | May 13, 2015 |
Antabio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AMR Action Fund | Series B |
| CARB-X | Grant |
| BNP Paribas Développement | Series A |
| iXO Private Equity | Series A |
| Turenne Groupe | Series B |
| Région Occitanie | Grant |
| Galia Gestion | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 2413% MoM, from 46 to 1.2K.
- Mar 23, 2026
Collaborates with GARDP Foundation to accelerate early-stage antibiotic discovery.
Antabio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antabio's valuation, stock price, and market status.
